Chester S. Zygmont III - 11 Feb 2025 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Chief Financial Officer
Signature
/s/ J.P. Galda, as attorney-in-fact for Chester S Zygmont III
Issuer symbol
REVB
Transactions as of
11 Feb 2025
Net transactions value
+$58,236
Form type
4
Filing time
13 Feb 2025, 18:05:34 UTC
Previous filing
28 Feb 2023
Next filing
31 Oct 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REVB Common Stock Award $58,236 +15,048 +53743% $3.87 15,076 11 Feb 2025 By Trust F1, F2
holding REVB Common Stock 28 11 Feb 2025 By Trust F2
holding REVB Common Stock 13 11 Feb 2025 By LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant.
F2 Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee.
F3 Shares are held by Czeslaw Capital Fund, LLC. Chester S Zygmont III is the sole manager of Czeslaw Capital Fund, LLC.